Vétoquinol SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0004186856
EUR
78.00
-2.4 (-2.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
OSE Immunotherapeutics SA
Vétoquinol SA
Ipsen SA
Sanofi
DBV Technologies SA
Genfit SA
Sensorion SA
Cellectis SA
MedinCell SA
Innate Pharma SA
PHAXIAM Therapeutics SA

Why is Vétoquinol SA ?

1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 52.59
2
Healthy long term growth as Net Sales has grown by an annual rate of 5.45%
3
Flat results in Jun 25
  • INVENTORY TURNOVER RATIO(HY) Lowest at 3.61 times
4
With ROE of 10.68%, it has a Attractive valuation with a 1.64 Price to Book Value
  • Over the past year, while the stock has generated a return of -3.82%, its profits have risen by 28.6% ; the PEG ratio of the company is 0.5
5
Below par performance in long term as well as near term
  • Along with generating -3.82% returns in the last 1 year, the stock has also underperformed France CAC 40 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Vétoquinol SA should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vétoquinol SA for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Vétoquinol SA
-3.82%
1.78
27.42%
France CAC 40
0.34%
-0.10
17.53%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.45%
EBIT Growth (5y)
9.60%
EBIT to Interest (avg)
52.59
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
1.02
Tax Ratio
25.25%
Dividend Payout Ratio
17.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.10%
ROE (avg)
10.04%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.64
EV to EBIT
10.35
EV to EBITDA
7.16
EV to Capital Employed
1.92
EV to Sales
1.42
PEG Ratio
0.54
Dividend Yield
1.14%
ROCE (Latest)
18.56%
ROE (Latest)
10.68%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 3.61 times

Here's what is working for Vétoquinol SA

Depreciation
Highest at EUR 16.49 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (EUR MM)

Here's what is not working for Vétoquinol SA

Inventory Turnover Ratio
Lowest at 3.61 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio